India  

Covaxin kids trial over, Bharat Biotech to submit data to DCGI next week

IndiaTimes Tuesday, 21 September 2021
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

Covaxin Covaxin Vaccine against COVID-19

No bail for Aryan Khan today, arguments to continue in Bombay High Court tomorrow | Oneindia News [Video]

No bail for Aryan Khan today, arguments to continue in Bombay High Court tomorrow | Oneindia News

The Bombay High Court will resume hearing Aryan Khan's bail plea at 2.30 pm tomorrow; A WHO technical advisory group reviewed data on Covaxin; Congress general secretary Priyanka Gandhi Vadra suggestion to party leaders; According to a study led by the University of Oxford in the UK, Covid-19 is more likely to cause very rare neurological conditions than vaccination with the AstraZeneca or Pfizer preventives. #BombayHC #AryanKhan #NCB

Credit: Oneindia    Duration: 02:18Published

Review of Covaxin by WHO underway; expect a recommendation within 24 hours: Spokesperson

Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine's Emergency Use..
IndiaTimes
WHO to take call on granting Covaxin Emergency Use Listing | Oneindia News [Video]

WHO to take call on granting Covaxin Emergency Use Listing | Oneindia News

World Health Orgaisation is expected to meet today to take a call on granting Covaxin Emergency use listing. It is expected that the vaccine will receive an EUL grant. #CovaxinEUL #SupremeCourtonLakhimpur #DaburKarvaChauthAd

Credit: Oneindia    Duration: 02:18Published

Bharat Biotech Bharat Biotech Indian multinational biotechnology company and vaccine manufacturer

We are waiting for DCGI approval for children's Covid-19 vaccine: Bharat Bitoech Chairman

Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said that they are waiting for approval from the Drugs Controller General of India..
IndiaTimes

WHO's technical advisory group to meet on Oct 26 to take call on Covaxin EUL

In a tweet late on Sunday night, World Health Organisation (WHO) chief scientist Soumya Swaminathan said, "WHO has been working closely with Bharat Biotech to..
IndiaTimes
Covaxin gets emergency use approval for children aged 2-18 years | Oneindia News [Video]

Covaxin gets emergency use approval for children aged 2-18 years | Oneindia News

In a big development today, the Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group. Meanwhile, Congress leader Priyanka Gandhi Vadra has reached Tikoniua to pay last respect to farmers who were killed in the October 3rd violence in Lakhimpur Kheri. Watch the video for this and more news at 2 PM. #Covaxin #IndianArmy #Farmers

Credit: Oneindia    Duration: 03:37Published
WHO expert panel to decide today on emergency use nod to Bharat Biotech’s Covaxin | Oneindia News [Video]

WHO expert panel to decide today on emergency use nod to Bharat Biotech’s Covaxin | Oneindia News

An expert panel of the WHO is going to take a decision on emergency use listing authorisation of Bharat Biotech’s Covaxin tentatively at 4:45 pm today. #Covaxin #WHO #EUL

Credit: Oneindia    Duration: 01:23Published

Drugs Controller General of India Drugs Controller General of India Director of CDSCO

You Might Like


Related news from verified sources

Covishield, Covaxin & Sputnik V: You can now identify COVID-19 fake vaccines with these steps

India is currently administering 3 vaccines - Covidshield, Covaxin and Sputnik V. Here are some ways in which you can identify if the vaccine is fake
DNA Also reported by •Zee News

Centre says two doses of Covaxin must even for Covid-cured people

A person must take two doses of the anti-Covid vaccine, Covaxin, even after recovering from Covid-19, for being considered as a fully vaccinated individual, a...
IndiaTimes

Covaxin may get WHO approval by month-end: NITI Aayog Member Dr VK Paul

India's indigenously-developed Covid vaccine Covaxin may soon receive Emergency Use Listing by the World Health Organisation, eventually enabling its recipients...
DNA Also reported by •Zee News